Related Experiment Video
Updated: Jan 1, 2026

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Infantile spasms followed by childhood absence epilepsy: A case series
Lucio Giordano1, Renato Tambucci2, Isabella Emanuela Cocco1
1Child Neuropsychiatric Division, Spedali Civili, Brescia, Italy.
Insights
Childhood absence epilepsy (CAE) may develop in infants with infantile spasms (IS) of unknown cause and favorable outcome. This study found that 29% of such children later developed CAE, suggesting a potential link.
Area of Science:
- Pediatric Neurology
- Epileptology
- Developmental Neuroscience
Background:
- Infantile spasms (IS) are a severe epilepsy syndrome in infants.
- IS are classified by etiology: known or unknown cause.
- Unknown cause IS with favorable outcome (UC/FO) have a generally good prognosis.
Purpose of the Study:
- To determine the prevalence of childhood absence epilepsy (CAE) in children with UC/FO IS.
- To investigate the potential association between UC/FO IS and the subsequent development of CAE.
Main Methods:
- Multicenter retrospective chart review across eight Italian pediatric epilepsy centers.
- Identification of children diagnosed with UC/FO IS who later developed CAE.
- Analysis of demographic, clinical, and treatment data.
Main Results:
- 29% (7 out of 24) of children with UC/FO IS were subsequently diagnosed with CAE.
- Mean age at IS onset was 5.8 months; seizure control was achieved by 8.5 months.
- CAE was diagnosed around 8.0 years, with most patients responding well to valproic acid.
Conclusions:
- A significant proportion of UC/FO IS patients developed CAE later in childhood.
- This association suggests a possible underlying thalamo-cortical dysfunction.
- Further research is needed to confirm causality.
Purpose:
Infantile spasms (IS) represent a severe seizure disorder of infancy and early childhood characterized by epileptic spasms along with hypsarrhythmia often accompanied by intellectual disability. According to the current classification and terminology (3) IS can be categorized as known etiology, formerly known as "symptomatic", when an underlying cause has been observed prior to the onset of spasms, or of "unknown cause" with "unfavorable" and "favorable" outcome (previously referred as "cryptogenic" or "idiopathic", respectively). Single reports described children with "unknown cause and favorable outcome" (UC/FO) IS who later developed childhood absence epilepsy (CAE). This study aims to determine the prevalence of CAE following IS.
Methods:
a multicenter retrospective chart review was performed; children with UC/FO IS who subsequently developed CAE during follow-up were identified. Eight Italian pediatric epilepsy centers participated in this study.
Results:
seven out of 24 (29 %) children (3 males) showing a favorable outcome (UC/FO) IS received a second diagnosis of CAE during follow-up. Mean age at IS presentation was 5.8 months (SD ± 0.9). All achieved seizure control of IS at a mean age of 8.5 months (SD ± 1.3) (3 monotherapy, 4 polytherapy). CAE was diagnosed at a mean age of 8.0 years (SD ± 3.0). Six children achieved sustained remission of CAE with valproic acid, whereas 1 child required dual therapy by adding ethosuximide.
Conclusion:
although it is not possible to determine whether the association between UC/FO IS and CAE implies a causality relationship, the later occurrence of CAE in patients with UC/FO IS might support a possible role of thalamo-cortical dysfunction.
More Related Videos
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists